ORIGINAL RESEARCH article

Front. Oncol.

Sec. Radiation Oncology

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1407606

This article is part of the Research TopicOptimizing Radiotherapy for Cervical Cancer Efficacy Toxicity and Brachytherapy IntegrationView all 5 articles

Reevaluating BED in Cervical Cancer HDR Brachytherapy: Source Decay and Tissue-Specific Repair Significantly Impact Radiobiological Dose

Provisionally accepted
Suyan  BiSuyan Bi1Jiaomei  ZhouJiaomei Zhou2Meiling  XuMeiling Xu2Zhitao  DaiZhitao Dai3*
  • 1Hospital Universiti Sains Malaysia, Health Campus, Universiti Sains Malaysia, Kota Bharu, Kelantan Darul Naim, Malaysia
  • 2National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China
  • 3Department of Radiation Therapy, Cancer Hospital Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China

The final, formatted version of the article will be published soon.

Objective This study aims to explore the influence of intrafraction DNA damage repair on biologically effective dose (BED) in Ir-192 high-dose-rate (HDR) brachytherapy (BT) for cervical cancer. Specifically, we aim to comprehensively investigate the BED variations triggered by source decay at diverse treatment time points across different tumor cell lines and normal tissues.Methods Instead of the simplified BED (BED) formula, which fails to account for intrafraction and interfraction repair as well as repopulation, we utilized the full-form BED (BEDg) formula.Subsequently, BED values for various subtypes of cervical cancer tissues and Organs at Risk (OARs) were calculated by applying both BED formulas throughout a source exchange cycle.The findings reveal that the BEDg values are notably smaller and exhibit a significant decrease as the source activity decays and the treatment time extends, in contrast to the BED values. Regarding the tumor, when α/β = 10, the maximum changes in BED (∆BED = BED -BEDg) amounted to 3.05±0.47% in D 90% of High-Risk Clinical Tumor Volume (HRCTV) in BT. Upon considering the subtypes of cervical cancer tissues, the three largest ∆BED (%) are determined to be 14.06±1.67, 9.92±1.19, and 7.57±1.05 in D 90% of HRCTV for α/β = 10 (stage I and II cervix carcinoma), α/β = 16.46 (HX156c), α/β = 11.40 (HX155c). Analogous results are also detected in OARs.As the source decays, the maximum ∆BED(%) ( α/β = 3) at D 0.1cc of the bladder, rectum, sigmoid, and small intestine reached 13.37±2.27, 11.92±2.10, 12.45±2.27, and 11.91±2.62, respectively. Conclusions This study validates that source decay has a substantial impact on the BED of cervical cancer tissues with distinct cell lines and normal tissues. Through the comparison between the full-form BED formula and the simplified one, it is evident that the latter has a tendency to overestimate the BED value, particularly when the source activity is 2 Ci.

Keywords: High-dose-rate brachytherapy (HDR BT), cervical cancer, Source Decay Impact, Tumor cell lines, Intrafraction Damage Repair, Biological Effective Dose (BED) Frontiers

Received: 26 Mar 2024; Accepted: 08 Apr 2025.

Copyright: © 2025 Bi, Zhou, Xu and Dai. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Zhitao Dai, Department of Radiation Therapy, Cancer Hospital Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

94% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more